Status:
COMPLETED
Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients
Lead Sponsor:
Denver Health and Hospital Authority
Collaborating Sponsors:
Accerl8 Technology Corporation
National Center for Research Resources (NCRR)
Conditions:
Ventilator Acquired Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Critically ill patients on a breathing machine are at risk of developing a type of pneumonia called Ventilator Acquired Pneumonia (VAP). The purpose of this study is to determine if regular lung rinse...
Detailed Description
Ventilator-associated pneumonia (VAP) is a common, life-threatening hospital-acquired infectious complication of prolonged mechanical ventilation (MV). Despite aggressive efforts to prevent VAP, rates...
Eligibility Criteria
Inclusion
- Written, informed consent (by surrogate if unconscious or if altered mental status)
- ≥ 18 years old
- Admission to a Medical Intensive care unit
- Orally/nasally intubated, evaluable within 72 h of initial intubation
- Expected to remain mechanically ventilated for at least 48 h after the first study procedure
Exclusion
- Previously documented cystic fibrosis
- Diffuse bronchiectasis
- Severe or massive hemoptysis
- Presence of an advanced directive to withhold life-sustaining treatment
- Morbid state or expected to survive less than 14 days because of an advanced co-morbid medical condition
- Participation in a clinical trial of any unlicensed drug or device within 30 days
- Pregnant or Nursing
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 19 2019
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00938002
Start Date
July 1 2009
End Date
September 19 2019
Last Update
December 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health Medical Center
Denver, Colorado, United States, 80204